Ticker: AXSM

Company: Axsome Therapeutics, Inc.

Person: Mark Coleman, director

Transaction date: Feb. 20, 2026

Reporting date: Feb. 23, 2026

Average share price: 4.95

Bought 12485.0 shares for 61800.75